Weis Markets, Inc. (WMK)
NYSEConsumer StaplesGrocery StoresSnapshot 2026-09-04
$71.98+0.73%
Close 2026-09-04 · 1-day change
NYSEConsumer StaplesGrocery StoresSnapshot 2026-09-04
QuarterlyIQ Insights · WMK
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 10.8% |
| Our one-year growth estimate | diamond | 4.2% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 6.6 percentage points more one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-09-04 · Compared with 5 industry peers · Company calendar date is not available
WMK — legal / regulatory event
Dated 2026-02-25
of its Current Report on Form 8-K dated February 20, 2026. The Company continues to work diligently to complete the remaining review and restatement procedures. The Company expects to file its Annual Report on Form 10-K for the 52-week fiscal year ended December 27, 2025, including all required restated financial statements, no later than March 12, 2026; however, the timing of the filing may be subject to further delay, and the Company cannot provide assurance regarding the definitive filing…
Why it matters: Improving cash flow shows better financial health. Strong cash flow supports future investments and dividends.
Supportive ifCash from operations is over $65 million in Q3.
Worry ifCash from operations is under $50 million in Q3.
Why it matters: An increase would show strong cash flow and commitment to returning value to shareholders.
Supportive ifThe company declares a dividend higher than $0.34 per share in Q3.
Worry ifThe company maintains or lowers the dividend at $0.34 per share in Q3.
Why it matters: Pharmacy revenue is crucial for overall growth. Significant impacts from pricing changes can hurt profits.
Worry ifPharmacy revenue impact from pricing headwinds exceeds $10 million in Q3.
Less concerning ifPharmacy revenue impact from pricing headwinds is less than $5 million in Q3.
Why it matters: A decline would signal trouble in managing costs and cash flow.
Worry ifCash from operations goes up compared to Q2.
Less concerning ifCash from operations goes down compared to Q2.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$111 on $10,000 · ±1.1% | How much price usually moves either way. |
| Bad day | $272 loss on $10,000 · 2.7% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $1,723 loss on $10,000 · 17.2% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: An increase shows strong financial health. It also shows a commitment to shareholders.
Supportive ifManagement says they will raise the dividend to $0.34 per share.
Worry ifManagement maintains the dividend at $0.34 per share without plans for an increase.
Why it matters: A decline signals ongoing problems in operations. This could hurt investor confidence.
Worry ifOperating income drops below $29 million in Q3.
Less concerning ifOperating income is over $30 million in Q3.
Why it matters: Changes to the dividend may show changes in financial strength or spending plans.
Watch forManagement says they will raise the quarterly cash dividend.
Also watch forManagement says they will lower or stop the quarterly cash dividend.
Why it matters: Stable or better operating income means better cost control. It also shows more efficiency.
Supportive ifOperating income reported at or above $36M for Q2 2026.
Worry ifOperating income was below $35M for Q2 2026. This shows ongoing challenges.
Why it matters: This would indicate a slowdown in customer spending and hurt revenue growth.
Worry ifComparable store sales growth for Q3 comes in below 2.0% year over year.
Less concerning ifComparable store sales growth for Q3 exceeds 2.0% year over year.
Why it matters: A larger impact means ongoing problems in the pharmacy area. This could hurt overall earnings.
Worry ifPharmacy revenue growth declines by more than $10 million due to pricing headwinds.
Less concerning ifPharmacy revenue growth declines by less than $10 million due to pricing headwinds.